Vascepa

DRUG2 trials

Sponsors

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, University of Louisville

Conditions

AtherosclerosisCoronary Artery DiseaseHeart AttackHypertriglyceridemia

Phase 4

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

CompletedNCT02926027

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterHypertriglyceridemia

Start: 2017-03-28End: 2020-08-15Updated: 2023-02-21

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

WithdrawnNCT06280976

University of LouisvilleAtherosclerosis, Coronary Artery Disease, Heart Attack

Start: 2024-03-01End: 2025-01-01Updated: 2025-03-17